Cel-Sci
CVM
#9791
Rank
โ‚น4.46 B
Marketcap
โ‚น531.52
Share price
-1.19%
Change (1 day)
-47.51%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น0.85 Billion

According to Cel-Sci 's latest financial reports the company's total debt is โ‚น0.85 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30โ‚น0.83 B-14.43%
2024-09-30โ‚น0.97 B-13.7%
2023-09-30โ‚น1.12 B-9.37%
2022-09-30โ‚น1.24 B5.02%
2021-09-30โ‚น1.18 B15.45%
2020-09-30โ‚น1.02 B7.23%
2019-09-30โ‚น0.95 B-1.25%
2018-09-30โ‚น0.97 B4.56%
2017-09-30โ‚น0.92 B6.68%
2016-09-30โ‚น0.86 B-4.43%
2015-09-30โ‚น0.90 B1212.44%
2014-09-30โ‚น69.33 M-2.23%
2013-09-30โ‚น70.91 M21.54%
2012-09-30โ‚น58.34 M-76.22%
2011-09-30โ‚น0.24 B398.78%
2010-09-30โ‚น49.2 M-6.93%
2009-09-30โ‚น52.86 M467.59%
2008-09-30โ‚น9.31 M
2005-09-30โ‚น0.13 M-4.34%
2004-09-30โ‚น0.13 M-99.66%
2003-09-30โ‚น39.99 M-53.41%
2002-09-30โ‚น85.85 M5645.84%
2001-09-30โ‚น1.49 M30.98%
2000-09-30โ‚น1.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น4.196 T 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.002 T 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น6.34 B 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น0.18 B-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.564 T 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚น59.14 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น60.76 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น50.58 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA